Drug Trial Radar · NCT07132112
GT719 Injection for Moderate to Severe Refractory Autoimmune Disease
Last checked: Nov 19, 2026Latest source record: Apr 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
30
Planned (sponsor's estimate)
Start
Oct 28, 2025
Primary completion
Aug 2028
Study completion Aug 2028
Sponsor
- Lead sponsor
- Grit BiotechnologyIndustry
- Sponsor type
- Industry
- Collaborators
- Affiliated Hospital of Nantong University
- First posted
- Aug 20, 2025
Design
- Study type
- Interventional
- Phase
- Early phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is a prospective single-arm open-label clinical trial, including dose escalation and expansion phase, aims to evaluate the safety, efficacy, and cellular pharmacokinetics of GT719 Injection in patients with moderate to severe refractory autoimmune disease. A total of 30 subjects will be enrolled in this study.
Conditions
- Auto Immune Disease
Interventions
GT719 InjectionBiological
GT719 Injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Proportion of participants experiencing dose limiting toxicityTime frame: 28 days
- Incidence of treatment-emergent adverse eventsTime frame: 2 years
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Affiliated Hospital of Nantong University
Nantong, Jiangsu, China · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.